Send us Feedback

Bristol-Myers Squibb Company (BMY)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
(Latest | Earliest) View (previous 50) (next 50)

Diff selection: mark the radio boxes of the versions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with current version, (last) = difference with preceding version, M = minor edit.

(cur)(last)03:13, September 19, 2011167.83.101.23 (Talk)
(cur)(last)21:17, September 18, 201183.125.19.12 (Talk) (→Research and Development ($3.57B in FY 2010))
(cur)(last)15:54, September 16, 201180.68.92.100 (Talk) (→Corporate Overview)
(cur)(last)13:06, September 16, 2011113.57.152.124 (Talk) (→Business Segments)
(cur)(last)21:52, May 2, 2011Smedoff (Talk | contribs) (→Comparison to Competitors)[stable]
(cur)(last)21:51, May 2, 2011Smedoff (Talk | contribs)[stable]
(cur)(last)21:48, May 2, 2011Smedoff (Talk | contribs)[stable]
(cur)(last)21:53, March 31, 2011Smedoff (Talk | contribs)[stable]
(cur)(last)23:49, November 28, 2010Kkparikh (Talk | contribs) (→Business Segments)[stable]
(cur)(last)22:00, October 26, 2010Kkparikh (Talk | contribs) (→Business and Financial Metrics)[stable]
(cur)(last)13:32, October 14, 2010Corinnetu (Talk | contribs)[stable]
(cur)(last)07:40, September 30, 2010Kkparikh (Talk | contribs) (→Recent Acquisitions)[stable]
(cur)(last)07:39, September 30, 2010Kkparikh (Talk | contribs) (→Recent Acquisitions)[stable]
(cur)(last)20:49, September 29, 2010Kkparikh (Talk | contribs)[stable]
(cur)(last)07:21, August 16, 2010Wraasch (Talk | contribs) (→References)[stable]
(cur)(last)01:33, August 16, 2010Drugmaroht (Talk | contribs) (→References)[stable]
(cur)(last)15:38, July 25, 2010Kkparikh (Talk | contribs) (→Business and Financial Metrics)[stable]
(cur)(last)13:46, July 11, 2010Gejordan (Talk | contribs) (→Corporate Overview)[stable]
(cur)(last)13:45, July 11, 2010Gejordan (Talk | contribs) (→Pharmaceuticals)[stable]
(cur)(last)13:44, July 11, 2010Gejordan (Talk | contribs) (→Business Segments)[stable]
(cur)(last)13:40, July 11, 2010Gejordan (Talk | contribs) (→Corporate Overview)[stable]
(cur)(last)13:39, July 11, 2010Gejordan (Talk | contribs)[stable]
(cur)(last)13:30, July 11, 2010Gejordan (Talk | contribs)[stable]
(cur)(last)08:24, June 25, 2010Kkparikh (Talk | contribs)[stable]
(cur)(last)08:23, June 25, 2010Kkparikh (Talk | contribs) (→Research and Development)[stable]
(cur)(last)08:22, June 25, 2010Kkparikh (Talk | contribs) (→Pricing Pressures)[stable]
(cur)(last)08:21, June 25, 2010Kkparikh (Talk | contribs) (→Trends and Forces)[stable]
(cur)(last)08:19, June 25, 2010Kkparikh (Talk | contribs) (→Drug Market Exclusivity and Generic Competition)[stable]
(cur)(last)23:08, April 14, 2010Wraasch (Talk | contribs)[stable]
(cur)(last)14:50, April 8, 2010Wraasch (Talk | contribs) (→Comparison to Competitors)[stable]
(cur)(last)02:36, March 30, 2010Allonz3 (Talk | contribs)[stable]
(cur)(last)19:40, February 1, 2010Wraasch (Talk | contribs)[stable]
(cur)(last)19:37, February 1, 2010Wraasch (Talk | contribs)[stable]
(cur)(last)14:31, December 25, 2009Wraasch (Talk | contribs) (→Drug Market Exclusivity and Generic Competition)[stable]
(cur)(last)11:44, December 25, 2009Wraasch (Talk | contribs) (→Drug Market Exclusivity and Generic Competition)[stable]
(cur)(last)10:35, December 25, 2009Wraasch (Talk | contribs) (→Business Growth)[stable]
(cur)(last)13:20, December 7, 200968.193.226.129 (Talk) (→Pharmaceuticals)[stable]
(cur)(last)09:06, November 29, 2009Wraasch (Talk | contribs) (→Nutritionals)[stable]
(cur)(last)21:00, October 26, 2009Wraasch (Talk | contribs) (→Business Growth)[stable]
(cur)(last)17:07, September 28, 2009Wraasch (Talk | contribs) (→Comparison to Competitors)[stable]
(cur)(last)10:00, August 29, 2009Wshikani (Talk | contribs) (→Business Growth)[stable]
(cur)(last)16:15, July 26, 2009Wshikani (Talk | contribs)[stable]
(cur)(last)00:50, June 25, 2009Armcharles (Talk | contribs)[stable]
(cur)(last)13:53, June 22, 2009Walim (Talk | contribs) (→References)[stable]
(cur)(last)07:45, May 30, 2009Wshikani (Talk | contribs) (→Comparison to Competitors)[stable]
(cur)(last)07:42, May 30, 2009Wshikani (Talk | contribs) (→Comparison to Competitors)[stable]
(cur)(last)11:43, May 29, 2009Wshikani (Talk | contribs)[stable]
(cur)(last)11:41, May 29, 2009Wshikani (Talk | contribs)m (→Business Segments)[stable]
(cur)(last)11:38, May 29, 2009Wshikani (Talk | contribs)m (→Business Segments)[stable]
(cur)(last)11:30, May 29, 2009Wshikani (Talk | contribs)[stable]
(Latest | Earliest) View (previous 50) (next 50)
Retrieved from "http://www.wikinvest.com/stock/Bristol-Myers_Squibb_Company_(BMY)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki